Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for OliPass

    Client Virtual Booth

    OLIPASS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    OliPass
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Tower 20th Floor, 16-4, 16 Beon-gil, Dongbaek Jungang-ro, Giheung-gu, Yongin, Gyeonggi 17015
    Telephone
    Telephone
    +82 . 2 . 6488 . 2232
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.olipass.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Vanda Pharm, OliPass partner to jointly develop antisense oligonucleotide
    Vanda Pharm, OliPass partner to jointly develop antisense oligonucleotide

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153606&sid=2

    PHARMABIZ
    01 Oct 2022
    Share Share
    Vanda Pharmaceuticals, OliPass Enter ASO R&D Alliance
    Vanda Pharmaceuticals, OliPass Enter ASO R&D Alliance

    https://www.contractpharma.com/contents/view_breaking-news/2022-09-30/vanda-pharmaceuticals-olipass-enter-aso-rd-alliance/

    CONTRACTPHARMA
    30 Sep 2022
    Share Share
    OliPass Moves Forward to Second Stage of PIIa Trial for Pain Killer OLP-1002
    OliPass Moves Forward to Second Stage of PIIa Trial for Pain Killer OLP-1002

    https://www.prnewswire.com/news-releases/olipass-moves-forward-to-second-stage-of-phase-2a-trial-for-pain-killer-olp-1002-301587849.html

    PRNEWSWIRE
    18 Jul 2022
    Share Share
    OliPass begins dosing in Phase IIa trial of painkiller for osteoarthritis
    OliPass begins dosing in Phase IIa trial of painkiller for osteoarthritis

    https://www.clinicaltrialsarena.com/news/olipass-dosing-osteoarthritis-trial/

    CLINICALTRIALSARENA
    22 Feb 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search